サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US

CountryFocus:米国における医療、規制、および医療費償還制度の展望

レポート概要

本レポートは、米国における医療、規制、および医療費償還制度の展望に関する情報や分析に不可欠な情報を提供し、医療市場における主要動向を明らかにします。また、人口動態、規制、医療費償還制度の展望、および医療インフラに関する見識を提供します。さらに、製薬および医療機器市場の動向やセグメントに関する貴重な情報を提供します。 本レポートは、業界の専門家からなる自社チームによる独自のデータベース、一次調査と二次調査、および自社分析を基にしたデータや情報を盛り込んでいます。

■調査範囲

  • 市場規模、市場セグメント、主要推進要因、および障壁など、米国における製薬および医療機器市場の概説
  • 主要企業のプロファイルとSWOT分析
    ➣ 主要製薬企業:Johnson & Johnson、Pfizer、Amgen、Merck、Abbvie
    ➣ 主要医療機器企業:Abbott、GE Healthcare、DePuy、Zimmer、Edwards
  • 米国の医薬品および医療機器市場における最近完了した取引に関する詳細な分析
  • 米国の医薬品・医療機器市場におけるPorter’s five forces分析
  • ヘルスケア償還プロセス、規制機関、新薬および医療機器の承認プロセスの詳細を含む、償還および規制状況の洞察を深めたレビュー
  • 最近の医療政策、医療インフラおよび医療費に関する情報
  • 米国の医療市場における成長の機会と成長の課題の概要

サンプルを見る

レポート詳細

目次

Table of Contents
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter’s Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix

List of Tables
Table 1: Average Gross Margin (%) on Various Drug Categories for Each Sector, Weighted by US Sales, 2015
Table 2: Pharmaceutical Market, Major Drugs Going Off-Patent, US Sales, 2017
Table 3: Pharmaceutical Market, Key Biologics Approval, US, 2018 (Jan 18-Aug 18)
Table 4: Pharmaceutical Market, US, Sales of Patented Drug Products by Major Therapeutic Class ($bn), 2015
Table 5: Medical Device Market, US, Revenue by Segment
Table 6: Orthopedic Devices Market, US, Revenue and Market Share of Major Players
Table 7: Cardiovascular Devices Market, US, Revenue and Market Share of Major Players
Table 8: In Vitro Diagnostics Devices Market, US, Revenue and Market Share of Major Players
Table 9: Healthcare IT Market, US, Revenue and Market Share of Major Players
Table 10: Ophthalmic Devices Market, US, Revenue and Market Share of Major Players
Table11: Overview of Public Insurance Providers, Federal Poverty Plans, US, 2018
Table 12: Overview of Public Insurance Providers, Metal Plans, US, 2018
Table 13: Overview of Public Insurance Providers, Value of Metal Plans, US, 2018
Table 14: Market Authorization for Biopharmaceutical Products, Biosimilar User Fee Act (BsUFA) Fees, 2018-2019, US
Table 15: Market Authorization for Medical Devices, Medical Device User Fee Amendments (MDUFA) Fees, 2018-2019, US
Table 16: Patent Fees, 2018, US
Table 17: Trade Associations, US
Table 18: Trade Fairs, US

List of Figures
Figure 1: Pharmaceutical Market, US, Revenue, 2015-2022
Figure 2: Medical Device Market, US, Revenue, 2015-2020
Figure 3: Number of Deals (2017-2018)
Figure 4: 2017-2018 Deal Overview By Region
Figure 5: Country Profile, US, 2018
Figure 6: Pharmaceutical Market, US, Revenue, 2010-2017
Figure 7: Pharmaceutical Market, US, Revenue Forecast, 2018-2022
Figure 8: Pharmaceutical Market, US, Pharmaceutical Exports
Figure 9: Pharmaceutical Market, US, Top Export Partners
Figure 10: Pharmaceutical Market, US, Pharmaceutical Imports
Figure 11: Pharmaceutical Market, US, Top Import Partners
Figure 12: Pharmaceutical Market, US, Supply Channels
Figure 13: Pharmaceutical Market, US, Drug Supply Chain Security Act: Implementation Timeline, 2013-2023
Figure 14: Pharmaceutical industry: Supply Chain Vulnerability, US
Figure 15: Pharmaceutical Market, US, Major Drugs Going Off-Patent, US, 2018-2022
Figure 16: Pharmaceutical Market, US, Generic Full Drug Approvals, US, 2013-2018*
Figure 17: Pharmaceutical Market, US, Key Generic Drug Approvals (Jan 18-Aug 18), 2018
Figure 18: Pharmaceutical Market, US, Top Selling Biologics Drugs, Sales, 2017
Figure 19: Pharmaceutical Market, US, Patent Expirations of Major Biologics, US, 2013-2028
Figure 20: Pharmaceutical Market, US Sales (Current and Forecast), Biologics Drugs Going Off-Patent, 2019-2021
Figure 21: Pharmaceutical Market, US, Number of Biosimilars Drug Approvals by EMA and USFDA, 2012-2018
Figure 22: Pharmaceutical Market, US, Key Events: Biosimilars Breakthroughs and Drug Approvals by EMA and FDA, 2001-2018
Figure 23: Pharmaceutical Market, US, Number of Biologics and Biosimilars Drug Approvals, USA, 2012-2018 (June 18)
Figure 24: Pharmaceutical Market, US, Biosimilars Approvals, 2017-2018
Figure 25: Pharmaceutical Market, Sales of OTC Products Based on Therapeutic Areas by Value and Volume ($ million), US, 2016
Figure 26: Pharmaceutical Market, US, Sales of Patented Drug Products by Major Therapeutic Class, 2015
Figure 27: Pharmaceutical Market, US, Major Players
Figure 28: Medical Device Market, US, Revenue, 2015-2020
Figure 29: Medical Device Market, US, Revenue Forecast, 2021-2025
Figure 30: Medical Device Market, US, Revenue by Segment, 2017
Figure 31: Orthopedic Devices Market, US, Revenue
Figure 32: Orthopedic Devices Market, US, Market Share of Major Players
Figure 33: Cardiovascular Devices Market, US, Revenue
Figure 34: Cardiovascular Devices Market, US, Market Share of Major Players
Figure 35: In Vitro Diagnostics Devices Market, US, Revenue
Figure 36: In Vitro Diagnostics Devices Market, US, Market Share of Major Players
Figure 37: Healthcare IT Market, US, Revenue
Figure 38: Healthcare IT Market, US, Market Share of Major Players
Figure 39: Ophthalmic Devices Market, US, Revenue
Figure 40: Ophthalmic Devices Market, US, Market Share of Major Players
Figure 41: Diagnostic Market, US, Revenue ($bn), 2010-2017
Figure 42: Diagnostic Market, US, Revenue Forecast ($bn), 2018-2022
Figure 43: Medical Device Market, US, Revenue of Major Players, 2016
Figure 44: Deal Value and Deal Count, Pharmaceutical Market, US, 2017-2018
Figure 45: Deal Value and Deal Count Quarterly, Pharmaceutical Market, US, 2017-2018
Figure 46: Deal Value and Deal Count Sub-types, Pharmaceutical Market, US, 2017-2018
Figure 47: Top Five Therapy Area by Deal Value, Pharmaceutical Market, US, 2017-2018
Figure 48: Top Five Therapy Area by Deal number, Pharmaceutical Market, US, 2017-2018
Figure 49: M&A Deals by Therapy Area, Pharmaceutical Market, US, 2017-2018
Figure 50: Venture Financing Deals by Therapy Area, Pharmaceutical Market, US, 2017-2018
Figure 51: Private Equity Deals by Therapy Area, Pharmaceutical Market, US, 2017-2018
Figure 52: Medical Device Market Deals, US, 2017-2018 (by deal value, $m)
Figure 53: Medical Device Market Deals, US, 2017- 2018 (by deal count)
Figure 54: Medical Device Market Deals Share (by deal count), US, 2017-2018
Figure 55: Medical Device Market Deals Share (by deal value), US, 2017-2018
Figure 56: Medical Device, Top Therapy Area by Deal Value, US, 2017-2018
Figure 57: Medical Device, Top Therapy Area by Deal Number, US, 2017-2018
Figure 58: M&A Deals by Therapy Area, Medical Device, US, 2017-2018 (by value and by number)
Figure 59: Venture Financing Deals by Therapy Area, Medical Device, US, 2017-2018 (by value and by number)
Figure 60: Private Equity Deals by Therapy Area, Medical Device US, 2017-2018 (by value and by number)
Figure 61: Healthcare System, Structure and Flow of Funds, US, 2018
Figure 62: Overview of Public and Private Insurance Provider, US, 2018
Figure 63: Components of Medicare Plan, Public Insurance, US, 2018
Figure 64: Doughnut Hole and Medicare Part D Coverage Gap, US, 2018
Figure 65: Premiums and Deductibles, Medicare, US, 2018
Figure 66: Features of Medicare and Medicaid Plan, US, 2018
Figure 67: Recent Advancements in Healthcare, DVA, US, 2016-2018
Figure 68: Overview of Private Insurance Plans, US, 2018
Figure 69: Various Types of Managed Care Plans, US, 2018
Figure 70: Major Components of National Health Expenditure (%), US, 2016
Figure 71: Overview of Affordable Care Act and American Health Care Act, US
Figure 72: Uninsured Rate, US, 2013-2018
Figure 73: OOP Expenditure (% of Total Expenditure on Health), US, 2010-2017
Figure 74: OOP Expenditure (OOP Expenditure per Capita), US, 2010-2017
Figure 75: Annual Rate of Change (%), Average Price of Prescription Drugs, US, 2010-2017
Figure 76: Pricing List at Different supply Chain Levels, US, 2018
Figure 77: FDA, Organizational Structure, US, 2018
Figure 78: Outline of the Clinical Development Process for a New Drug, US, 2017
Figure 79: Outline of Clinical Development Process for Generic Drug, US
Figure 80: Outline of Biological Products Licensure Process, US, 2018
Figure 81: Medical Device Approval Process, US, 2016
Figure 82: Patent Approval Process, US, 2018
Figure 83: Trademark Approval Process, US, 2018
Figure 84: Number of Hospitals, US, 2010-2017
Figure 85: Number of Ambulatory Surgery Centers (ASCs), US, 2010-2017
Figure 86: CT Scanners and MRI Units (per million population), US, 2010-2017
Figure 87: Mammography Units (per million population), US, 2010-2017
Figure 88: Hospital Beds (per 1,000 population), US
Figure 89: Acute Care Hospital Beds (per 1,000 population), US
Figure 90: Psychiatric Hospital Beds (per 1,000 population), US
Figure 91: Life Expectancy, 2010-2017, US
Figure 92: Elderly population (% of total population), 2010-2017, US
Figure 93: Immunization Rate (%), DPT, 2010-2017, US
Figure 94: Immunization Rate (%), Measles, 2010-2017, US
Figure 95: PM2.5 (μg per m3), US, 2010-2016
Figure 96: CO2 Emissions (million tons), US, 2010-2016
Figure 97: Physicians (per 1,000 population), US, 2010-2016
Figure 98: Nurses (per 1,000 population), US, 2010-2016
Figure 99: Dentists (per 1,000 population), US, 2010-2016
Figure 100: Pharmacists (per 1,000 population), US, 2010-2016
Figure 101: Major Causes of Mortality (per 1,000 population), US, 2015
Figure 102: Major Causes of Male Mortality, US, 2015
Figure 103: Major Causes of Female Mortality, US, 2015
Figure 104: Disability-Adjusted Life Years by Major Disease (‘000), US, 2016
Figure 105: Healthcare Expenditure as Percentage of GDP (%), US, 2010-2017
Figure 106: Public-Private Share (%), US, 2010-2017
Figure 107: Major Components of Healthcare Spending (%), US, 2016
Figure 108: Opportunities and Challenges, US

発刊日

2018/10/10

体裁

PDF / 169ページ

販売価格

1,995USD

発行

GlobalData

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医薬品産業(医療制度、医療観光など)

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE